Ichiro Tsujio

554 total citations
11 papers, 454 citations indexed

About

Ichiro Tsujio is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ichiro Tsujio has authored 11 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ichiro Tsujio's work include Alzheimer's disease research and treatments (9 papers), Prion Diseases and Protein Misfolding (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Ichiro Tsujio is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Prion Diseases and Protein Misfolding (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Ichiro Tsujio collaborates with scholars based in Japan, United States and Sweden. Ichiro Tsujio's co-authors include Khalid Iqbal, Inge Grundke‐Iqbal, Masatoshi Takeda, Sabiha Khatoon, Jin-Jing Pei, Takashi Kudo, Toshihisa Tanaka, Tanweer Zaidi, Irina Alafuzoff and Richard F. Cowburn and has published in prestigious journals such as FEBS Letters, Acta Neuropathologica and Clinica Chimica Acta.

In The Last Decade

Ichiro Tsujio

11 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ichiro Tsujio Japan 10 228 222 138 71 56 11 454
Qun Wang China 11 287 1.3× 286 1.3× 128 0.9× 59 0.8× 64 1.1× 19 557
Kristina K. Beiswenger United States 6 327 1.4× 186 0.8× 152 1.1× 71 1.0× 54 1.0× 6 613
Keith D. Coon United States 8 211 0.9× 293 1.3× 83 0.6× 60 0.8× 27 0.5× 10 475
Rejith Dayanandan United Kingdom 10 402 1.8× 309 1.4× 187 1.4× 87 1.2× 117 2.1× 17 588
Annemieke A.M. Rensink Netherlands 7 249 1.1× 132 0.6× 60 0.4× 70 1.0× 42 0.8× 8 368
Katsue Miyoshi Japan 8 288 1.3× 188 0.8× 92 0.7× 64 0.9× 87 1.6× 11 484
Yongbo Zhao China 9 229 1.0× 235 1.1× 74 0.5× 56 0.8× 37 0.7× 17 517
Anna Oczkowska Poland 7 184 0.8× 194 0.9× 109 0.8× 148 2.1× 45 0.8× 13 496
Kang-Wu Li United States 9 378 1.7× 211 1.0× 210 1.5× 79 1.1× 110 2.0× 9 594
L. Anderson United States 6 370 1.6× 363 1.6× 117 0.8× 30 0.4× 55 1.0× 11 536

Countries citing papers authored by Ichiro Tsujio

Since Specialization
Citations

This map shows the geographic impact of Ichiro Tsujio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Tsujio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Tsujio more than expected).

Fields of papers citing papers by Ichiro Tsujio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Tsujio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Tsujio. The network helps show where Ichiro Tsujio may publish in the future.

Co-authorship network of co-authors of Ichiro Tsujio

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Tsujio. A scholar is included among the top collaborators of Ichiro Tsujio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Tsujio. Ichiro Tsujio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tanimukai, Hitoshi, Hiroshi Tsujimoto, Yoshinobu Matsuda, et al.. (2014). Novel Therapeutic Strategies for Delirium in Patients With Cancer. American Journal of Hospice and Palliative Medicine®. 33(5). 456–462. 12 indexed citations
3.
Iqbal, Khalid, Alejandra del C. Alonso, Ezzat El-Akkad, et al.. (2003). Alzheimer Neurofibrillary Degeneration: Therapeutic Targets and High-Throughput Assays. Journal of Molecular Neuroscience. 20(3). 425–430. 25 indexed citations
4.
Pei, Jin-Jing, Sabiha Khatoon, Wenlin An, et al.. (2002). Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathologica. 105(4). 381–392. 138 indexed citations
5.
Iqbal, Khalid, Alejandra del C. Alonso, Ezzat El-Akkad, et al.. (2002). Significance and mechanism of alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion. Journal of Molecular Neuroscience. 19(1-2). 95–99. 47 indexed citations
6.
Iqbal, Khalid, Ezzat El-Akkad, Cheng‐Xin Gong, et al.. (2002). Pharmacological targets to inhibit alzheimer neurofibrillary degeneration. Journal of neural transmission. Supplementum. 309–319. 15 indexed citations
7.
Tsujio, Ichiro, Toshihisa Tanaka, Takashi Kudo, et al.. (2000). Inactivation of glycogen synthase kinase‐3 by protein kinase C δ: implications for regulation of τ phosphorylation. FEBS Letters. 469(1). 111–117. 78 indexed citations
8.
Tanaka, Toshihisa, Ichiro Tsujio, Takashi Nishikawa, et al.. (2000). Significance of Tau Phosphorylation and Protein Kinase Regulation in the Pathogenesis of Alzheimer Disease. Alzheimer Disease & Associated Disorders. 14(Supplement). S18–S24. 10 indexed citations
9.
Kudo, Takashi, Tatsuo Mima, Ryota Hashimoto, et al.. (2000). Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry and Clinical Neurosciences. 54(2). 199–202. 53 indexed citations
10.
Tanimukai, Hitoshi, et al.. (1999). Presenilin-2 mutation and polymorphism in Japanese Alzheimer disease patients. Clinica Chimica Acta. 283(1-2). 57–61. 1 indexed citations
11.
Hashimoto, Ryota, et al.. (1999). Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system. Psychiatry and Clinical Neurosciences. 53(5). 587–591. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026